Tramadol iv. : Influence of Dose and Dose Intervals on Therapeutic Accuracy and Side Effects When Used for Postoperative Pain Relief in Ambulatory Surgery
NCT00333346 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2010-08-31
Summary
The aim of this study is to compare the administration of 1 unit dose of 100 mg tramadol intravenously versus multiple smaller dosages of tramadol during the first 6 hours post-operatively and to investigate the time course and accuracy of pain relief versus the onset and duration of side-effects.
Conditions
- Ambulatory Surgery
Interventions
- DRUG
-
Administration of tramadol intravenously
Sponsors & Collaborators
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Michel Struys, MD, PhD · University Hospital, Ghent
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2009-04-30
- Completion
- 2009-04-30
Countries
- Belgium
Study Locations
More Related Trials
-
A Study to Compare the Bioavailability of Two Tramadol Hydrochloride Tablet Products (50 mg and 200 mg, Respectively) at Steady-state Under Fasting Conditions
NCT00834288 ·Status: COMPLETED ·Phase: PHASE1
-
Timecost of Intranasal Versus Intravenous Analgesia in Traumatic Pain
NCT06351137 ·Status: COMPLETED ·Phase: NA
-
Impact of Tramadol Addiction On Dental Anesthesia Success
NCT05908305 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of Tramadol as a Treatment for Opioid Addiction
NCT00301210 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis
NCT07238179 ·Status: ACTIVE_NOT_RECRUITING
-
A Pharmacodynamic/Pharmacokinetic Study to Determine the Onset of Analgesic Effect and Plasma Levels of Tramadol in Patients With Acute Low Back Pain Receiving a Single 200 mg Dose of Tramadol Contramid® Once-a-Day
NCT00952068 ·Status: COMPLETED ·Phase: PHASE2
-
Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis
NCT03477851 ·Status: COMPLETED ·Phase: PHASE4
-
Pain Relief - Tramadol Versus Ibuprofen
NCT00111046 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Early Pain Management at Triage on Opioid Consumption
NCT03243006 ·Status: COMPLETED ·Phase: NA
-
A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee (With 7-Day Follow-up)
NCT00852917 ·Status: COMPLETED ·Phase: PHASE3
-
Tramadol to Reduce Opioid Withdrawal Symptoms
NCT00142896 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Finding Study of STR-324
NCT04582786 ·Status: UNKNOWN ·Phase: PHASE2
-
A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol OAD Tablets to Twice Daily Tramadol BID for the Treatment of Osteoarthritis of the Knee (Extension Protocol) and Open Label Safety Follow-Up
NCT00912015 ·Status: COMPLETED ·Phase: PHASE3
-
PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects
NCT02329561 ·Status: COMPLETED ·Phase: PHASE1
-
A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.
NCT00347685 ·Status: COMPLETED ·Phase: PHASE3
-
Omnitram Pharmacokinetic Study In Healthy Volunteers
NCT02205554 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Tramadol on Opioid-induced Bowel Dysfunction
NCT06385561 ·Status: COMPLETED ·Phase: PHASE2
-
Fast-Release Orodispersible Tramadol Tablet (Tradonal Odis®) as Analgesia for Hysterosalpingography
NCT00893412 ·Status: COMPLETED ·Phase: PHASE4
-
Is There an Ideal Dose of Intravenous Fentanyl in the Prehospital Setting
NCT02914678 ·Status: COMPLETED ·Phase: NA
-
Suicide Attempts and Tramadol : a Case Report
NCT05075291 ·Status: COMPLETED
-
CYTRAM (Cytochrome P450, Tramadol)
NCT00952159 ·Status: COMPLETED
-
An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee
NCT00833911 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
NCT02307864 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Between Two Tramadol Formulations: Study of the Better Controlled Release of a New 200 mg Once A Day (OAD) Formulation Versus Zytram® 200 mg
NCT00911742 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Two Tramadol Contramid® OAD 300 mg Controlled-Release Tablets From Two Different Manufacturing Sites Following a 300 mg Dose in Healthy Subjects Under Fasting and Fed Conditions
NCT00834912 ·Status: COMPLETED ·Phase: PHASE1